U.S. PRP And Stem Cell Alopecia Treatment Market Growth & Trends
The U.S. PRP and stem cell alopecia treatment market size is anticipated to reach USD 438.91 million by 2030. The market is projected to grow at a CAGR of 9.46% from 2025 to 2030. Factors contributing to the growth of this market include rise in disease awareness, increased treatment rate, and growing adoption of novel treatment therapies providing a positive patient outcome. Moreover, lower incidence of negative side effects due to this therapy is anticipated to fuel demand for platelet-rich plasma (PRP) and stem cell therapy.Adoption of PRP and stem cell therapy for alopecia is expected to increase owing to a rise in the number of patients preferring novel therapies over conventional therapies. In addition to this, shorter treatment duration, faster hair regrowth, and improved patient outcome are expected to drive demand for these therapies over the forecast period.
By treatment type, PRP procedures accounted for the largest share of 58.1% in 2017 in terms of procedural volume. However, owing to lower prices of PRP procedures, stem cell therapy procedures accounted for the dominant revenue share in 2017, valued at USD 70.1 million. By end use, the dermatology clinics segment accounted for 85.0% of the total market revenue in 2017, owing to its lower therapy cost as compared to hospitals.
The competitive landscape includes clinics such as Orange County Hair Restoration Center, Hair Sciences Center of Colorado, Evolution Hair Loss Institute, Savola Aesthetic Dermatology Center, PLC, NovaGenix, Virginia Surgical Center, and Hair Transplant Institute of Miami.
U.S. PRP And Stem Cell Alopecia Treatment Market Report Highlights
- Stem cell therapy is expected to grow significantly at a CAGR of 12.47% over the forecast period, owing to its promising applications in treating various conditions, including hair loss and degenerative diseases.
- Androgenic alopecia dominated the market and accounted for the largest revenue share of 71.51% in 2024 attributed to its high prevalence, affecting approximately 50 million men and 30 million women.
- Dermatology clinics dominated the market and accounted for the largest revenue share of 69.60% in 2024 driven by the rising prevalence of skin conditions and hair loss disorders, such as androgenic alopecia.
Why should you buy this report?
- Comprehensive Market Analysis: Gain detailed insights into the global market across major regions and segments.
- Competitive Landscape: Explore the market presence of key players worldwide.
- Future Trends: Discover the pivotal trends and drivers shaping the future of the global market.
- Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.
This report addresses:
- Market intelligence to enable effective decision-making
- Market estimates and forecasts from 2018 to 2030
- Growth opportunities and trend analyses
- Segment and regional revenue forecasts for market assessment
- Competition strategy and market share analysis
- Product innovation listing for you to stay ahead of the curve
- COVID-19's impact and how to sustain in these fast-evolving markets
Table of Contents
Chapter 1. Methodology and Scope
Chapter 2. Executive Summary
Chapter 3. U.S. PRP & Stem Cell Alopecia Treatment Market Variables, Trends, & Scope
Chapter 4. U.S. PRP & Stem Cell Alopecia Treatment Market: Treatment Estimates & Trend Analysis
Chapter 5. U.S. PRP & Stem Cell Alopecia Treatment Market: Indication Estimates & Trend Analysis
Chapter 6. U.S. PRP & Stem Cell Alopecia Treatment Market: End Use Estimates & Trend Analysis
Chapter 7. Competitive Landscape
List of Tables
List of Figures
Companies Mentioned
- Bauman Medical Group, P.A.
- Virginia Surgical Center
- Nova Medical Hair Transplant
- Chicago Hair Transplant Clinic
- Dr. V Medical Aesthetics
- City Facial Plastics
- Orange County Hair Restoration
- MAXIM Hair Restoration
- New Jersey Hair Restoration Center
- Hair Restoration Institute of Minnesota
- Morgenstern Hair Restoration LLC.
- Houston Hair Transplant Center
Methodology
LOADING...
Table Information
Report Attribute | Details |
---|---|
No. of Pages | 70 |
Published | December 2024 |
Forecast Period | 2024 - 2030 |
Estimated Market Value ( USD | $ 255.2 million |
Forecasted Market Value ( USD | $ 438.91 million |
Compound Annual Growth Rate | 9.4% |
Regions Covered | United States |
No. of Companies Mentioned | 12 |